Multilineage cells from human adipose tissue: implications for cell-based therapies

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Tissue Engineering

Background:

• Autologous pluripotent stem cells are crucial for future cell-based therapies.
• Mesenchymal stem cells (MSCs) from bone marrow stroma are a potential source but have procurement limitations.
• An accessible, minimally invasive source of autologous adult stem cells is needed.

Purpose of the Study:

• To investigate the potential of isolating multipotent stem cells from human adipose tissue.
• To characterize these cells for their proliferative capacity, senescence, and cellular origin.
• To assess their differentiation potential into various mesodermal lineages.

Main Methods:

• Isolation and processing of human adipose tissue obtained via liposuction to yield processed lipoaspirate (PLA) cells.
• In vitro culture to assess cell maintenance, population doubling, and senescence.
• Immunofluorescence and flow cytometry to determine cell origin and purity.
• In vitro differentiation assays using lineage-specific induction factors.

Main Results:

• PLA cells demonstrated stable proliferation and low senescence in vitro.
• Flow cytometry indicated a mesodermal/mesenchymal origin with minimal contamination.
• PLA cells successfully differentiated into adipogenic, chondrogenic, myogenic, and osteogenic cells.
• These findings support the multipotency of cells derived from lipoaspirate.

Conclusions:

• Human adipose tissue contains multipotent stem cells.
• Processed lipoaspirate (PLA) cells represent a viable alternative stem cell source compared to bone marrow-derived MSCs.
• PLA cells hold potential for applications in tissue engineering and regenerative medicine.